{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:03:32Z","timestamp":1789499012329,"version":"build-2803163510"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Research Projects of Hunan Provincial Department of Education","award":["23A0665"],"award-info":[{"award-number":["23A0665"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,26]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      We performed a 2-step Mendelian randomization (MR) study to investigate the associations of Fms-related tyrosine kinase 3 ligand (FLT3L) and phosphate levels with the risk of hypertrophic cardiomyopathy (HCM). Genetic instruments for 75 circulating inflammatory factors were obtained from the NHGRI-EBI GWAS Catalog, while summary statistics for circulating phosphate and HCM were derived from the UK Biobank and FinnGen, respectively. Univariable MR analysis using the inverse-variance weighted method indicated that genetically predicted higher phosphate levels were associated with an increased risk of HCM (OR\u2005=\u20051.36,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20054.82\u2005\u00d7\u200510\n                      <jats:sup>\u22122<\/jats:sup>\n                      ). Among the inflammatory markers, FLT3L emerged as a significant candidate and showed inverse associations with phosphate levels (\u03b2\u2005=\u2005-0.05,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20051.70\u2005\u00d7\u200510\n                      <jats:sup>\u22129<\/jats:sup>\n                      ) and HCM (OR\u2005=\u20050.79,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20054.10\u2005\u00d7\u200510\n                      <jats:sup>\u22122<\/jats:sup>\n                      ). Bidirectional MR analyses did not support a causal effect of phosphate on FLT3L. Mediation analysis suggested that phosphate levels accounted for an estimated 12.05% of the total effect of FLT3L on HCM. Genetic liability to lower FLT3L levels is associated with a higher risk of HCM, and this relationship may be partially mediated through circulating phosphate levels.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049477","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:00:59Z","timestamp":1782496859000},"page":"e49477","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Genetically predicted lower FLT3L levels increase the risk of hypertrophic cardiomyopathy partly mediated by phosphate: Evidence from a 2-step Mendelian randomization analysis"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8783-4738","authenticated-orcid":false,"given":"Yanhui","family":"Li","sequence":"first","affiliation":[{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Pharmaceutical Science, Changsha Medical University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeng","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Hou","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zheng","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Zheng","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghua","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Liao","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Pharmaceutical Science, Changsha Medical University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Bao","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Pharmaceutical Science, Changsha Medical University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Stomatology, Changsha Medical University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4496-5050","authenticated-orcid":false,"given":"Sen","family":"Li","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-20260915","first-page":"1728","article-title":"Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.","volume":"38","author":"Weissler-Snir","year":"2017","journal-title":"Eur Heart J"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity.","volume":"53","author":"Harper","year":"2021","journal-title":"Nat Genet"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy.","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s44348-025-00054-5","article-title":"Evaluation of sudden cardiac death in hypertrophic cardiomyopathy.","volume":"33","author":"Yoon","year":"2025","journal-title":"J Cardiovascular Imag"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11239-019-02026-1","article-title":"Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy.","volume":"49","author":"Becker","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R8-20260915","first-page":"5063","article-title":"Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.","volume":"9","author":"Fang","year":"2017","journal-title":"Am J Transl Res"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"e70463","DOI":"10.1002\/mco2.70463","article-title":"Circulating interleukin-6 predicts adverse outcomes in asians with hypertrophic cardiomyopathy.","volume":"6","author":"Le","year":"2025","journal-title":"MedComm (2020)"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"1645382","DOI":"10.3389\/fimmu.2025.1645382","article-title":"Integration of multi-omics and machine learning strategies identifies immune related candidate biomarkers in inflammation-associated hypertrophic cardiomyopathy.","volume":"16","author":"Liang","year":"2025","journal-title":"Front Immunol"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bcp.12117","article-title":"Phosphate: an old bone molecule but new cardiovascular risk factor.","volume":"77","author":"Shobeiri","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/ATVBAHA.123.319198","article-title":"Phosphate in cardiovascular disease: from new insights into molecular mechanisms to clinical implications.","volume":"44","author":"Turner","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/ijms27010408","article-title":"Phosphate and inflammation in health and kidney disease.","volume":"27","author":"Novillo-Sarmiento","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jad.2024.08.009","article-title":"The effect of depression status on osteoarthritis: a powerful two-step mendelian randomization study.","volume":"364","author":"Yan","year":"2024","journal-title":"J Affect Disord"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation.","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.3390\/nu15133013","article-title":"Genetic association and potential mediators between sarcopenia and coronary heart disease: a bidirectional two-sample, two-step mendelian randomization study.","volume":"15","author":"He","year":"2023","journal-title":"Nutrients"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"1321576","DOI":"10.3389\/fendo.2023.1321576","article-title":"Endocrine and metabolic factors and the risk of idiopathic pulmonary fibrosis: a mendelian randomization study.","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12916-022-02657-x","article-title":"Association between gut microbiota and preeclampsia-eclampsia: a two-sample mendelian randomization study.","volume":"20","author":"Li","year":"2022","journal-title":"BMC Med"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"1250509","DOI":"10.3389\/fnut.2023.1250509","article-title":"Sodium intake and the risk of various types of cardiovascular diseases: a mendelian randomization study.","volume":"10","author":"Fu","year":"2023","journal-title":"Front Nutr"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"1295040","DOI":"10.3389\/fendo.2023.1295040","article-title":"Assessing causal associations of hyperparathyroidism with blood counts and biochemical indicators: a mendelian randomization study.","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"e40412","DOI":"10.1097\/MD.0000000000040412","article-title":"Exploring the causal relationships between type 2 diabetes and neurological disorders using a mendelian randomization strategy.","volume":"103","author":"Wei","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"104537","DOI":"10.1016\/j.ebiom.2023.104537","article-title":"The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study.","volume":"90","author":"Kintu","year":"2023","journal-title":"EBioMedicine"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"1276836","DOI":"10.3389\/fendo.2023.1276836","article-title":"Assessment of potential risk factors associated with gestational diabetes mellitus: evidence from a mendelian randomization study.","volume":"14","author":"Fu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"e41861","DOI":"10.1097\/MD.0000000000041861","article-title":"Causal associations between HbA1c and multiple diseases unveiled through a mendelian randomization phenome-wide association study in East Asian populations.","volume":"104","author":"Han","year":"2025","journal-title":"Medicine (Baltim)"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"e38610","DOI":"10.1097\/MD.0000000000038610","article-title":"Assessing causal associations of bile acids with obesity indicators: a mendelian randomization study.","volume":"103","author":"Huang","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jacc.2013.08.1647","article-title":"FLT3 activation improves post-myocardial infarction remodeling involving a cytoprotective effect on cardiomyocytes.","volume":"63","author":"Pfister","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"e202101112","DOI":"10.26508\/lsa.202101112","article-title":"Fms-like tyrosine kinase 3 is a regulator of the cardiac side population in mice.","volume":"5","author":"Della Verde","year":"2021","journal-title":"Life Sci Alliance"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jacc.2013.09.058","article-title":"Yet another player in the cardio-oncology conundrum?: deciphering the role of FLT3.","volume":"63","author":"Barac","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10495-023-01911-8","article-title":"The Flt3-inhibitor quizartinib augments apoptosis and promotes maladaptive remodeling after myocardial infarction in mice.","volume":"29","author":"Monogiou Belik","year":"2024","journal-title":"Apoptosis"},{"key":"R33-20260915","first-page":"1657","article-title":"Flt3 activation mitigates mitochondrial fragmentation and heart dysfunction through rebalanced L-OPA1 processing by hindering the interaction between acetylated p53 and PHB2 in cardiac remodeling.","volume":"12","author":"Zhang","year":"2023","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.hrtlng.2024.04.018","article-title":"Causal role of circulating inflammatory cytokines in cardiac diseases, structure and function.","volume":"67","author":"Ruan","year":"2024","journal-title":"Heart Lung"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11033-025-10396-4","article-title":"Effect of FLT3 ligand on the gene expression of TIM-3, HIF1-\u03b1, and TNF-\u03b1 in an acute myeloid leukemia cell line.","volume":"52","author":"Heidari","year":"2025","journal-title":"Mol Biol Rep"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MNH.0000000000000232","article-title":"Inflammation regulates fibroblast growth factor 23 production.","volume":"25","author":"Francis","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"588096","DOI":"10.3389\/fendo.2021.588096","article-title":"Upstream regulators of fibroblast growth factor 23.","volume":"12","author":"Ratsma","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R38-20260915","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00359.2016","article-title":"Ironing out the cross talk between FGF23 and inflammation.","volume":"312","author":"David","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"e164610","DOI":"10.1172\/JCI164610","article-title":"Kidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis.","volume":"133","author":"Zhou","year":"2023","journal-title":"J Clin Invest"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.RV22012","article-title":"Phosphate and coronary artery disease in patients with chronic kidney disease.","volume":"31","author":"Ogata","year":"2024","journal-title":"J Atheroscler Thromb"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0192623317737469","article-title":"Pleiotropic actions of FGF23.","volume":"45","author":"Erben","year":"2017","journal-title":"Toxicol Pathol"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/s41598-017-02068-6","article-title":"FGF23\/FGFR4-mediated left ventricular hypertrophy is reversible.","volume":"7","author":"Grabner","year":"2017","journal-title":"Sci Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:09:40Z","timestamp":1789495780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":40,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049477","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"2026-01-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}